José Miguel Alvarez Blanco, MD, Ana Sierra Salazar, MD^*, Juan Rangel-Patiño, MD and Roberta Demichelis, MD

Department of Hematology and Oncology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico

Sanjay Khandelwal, PhD¹, Lubica Rauova, MD, PhD², Ayiesha Barnes, MS^1*, Ann Rux^3*, Serge Yarovoi^3*, Sooho S Myoung^1*, Alexandra Johnson^1*, Grace M Lee, MD¹, Madelaine Duarte, BA^1*, Mortimer Poncz, MD², Gowthami M. Arepally, MD¹ and Douglas B. Cines, MD³

¹Division of Hematology, Duke University Medical Center, Durham, NC
²Children's Hospital of Philadelphia, Philadelphia, PA
³Department of Pathology and Laboratory Medicine, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, PA

Maria Selvadurai, PhD, BSc^1,2*, Christine Lee^1*, James Yeung, MBBS^1,3*, Maria Konda^4*, Geoffrey Kershaw^1,5*, Emmanuel Favaloro^6,7,8* and Vivien Chen, PhD MBBS^1,3

¹ANZAC Research Institute, University of Sydney, Sydney, NSW, Australia
²Faculty of Medicine, Nursing and Health Sciences, Monash University, St Kilda East, VIC, Australia
³Department of Haematology, Concord Repatriation General Hospital, Sydney, NSW, Australia
⁴Diagnostic Pathology Unit, Concord Repatriation General Hospital, Sydney, NSW, Australia
⁵Institute of Haematology, Royal Prince Alfred Hospital, Sydney, NSW, Australia
⁶Sydney Centres for Thrombosis and Haemostasis, Westmead, NSW, Australia
⁷School of Biomedical Sciences, Charles Sturt University, Wagga Wagga, NSW, Australia
⁸Westmead Hospital, Westmead, NSW, Australia

Shawn Jindal, MD^1*, Christopher Leyton, MD^2*, Fred Cohen, MD^2*, Morayma Reyes Gil, MD, PhD^3* and Henny H. Billett, MD, MSc⁴

¹Department of Internal Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, New York, NY
²Department of Internal Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY
³Department of Pathology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY
⁴Division of Hematology, Department of Internal Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY

David J. Kuter, MD¹, Merlin Efraim, MD^2*, Jiri Mayer, MD³, Vickie McDonald, MD^4*, Robert J. Bird, FRACP, FRCP, FRCPA, MBBS, MRCP^5*, Thomas Regenbogen, MD^6*, Mamta Garg, MD, FRCP, FRCPath^7*, Zane Kaplan, MBBS(Hons) BMedSc(Hons) PhD FRACP FRCPA⁸, Olga Bandman, MD^9*, Regan Burns^9*, Ann Neale^9*, Dolca Thomas, MD^9* and Nichola Cooper, MD, MRCP¹⁰

¹Hematology Division, Massachusetts General Hospital, Boston, MA
²Multiprofile Hospital for Active Treatment Sveta Marina EAD, Varna, Bulgaria
³Department of Internal Medicine, Hematology and Oncology, Masaryk University Hospital, Brno, Czech Republic
⁴Barts Health NHS Trust, The Royal London Hospital, London, United Kingdom
⁵Department of Haematology, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia
⁶MidMichigan Medical Center, Midland, MI
⁷Leicester Royal Infirmary, Leicester, United Kingdom
⁸Monash Medical Center, Clayton, Victoria, Australia
⁹Principia Biopharma Inc., South San Francisco
¹⁰Department of Medicine, Hammersmith Hospital, London, United Kingdom

Catherine M. Broome^1*, Alexander Röth, MD², David J. Kuter, MD³, Marie Scully, MD⁴, Roy Smith⁵, Jennifer Wang^6*, Xiaoyu Jiang^6*, Caroline Reuter^6*, Ahmed Daak^6* and William Hobbs⁶

¹Division of Hematology, MedStar Georgetown University Hospital, Washington, D.C.
²Department of Hematology, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
³Division of Hematology, Massachusetts General Hospital, Harvard Medical School, Boston, MA
⁴Department of Haematology, University College London Hospitals, Cardiometabolic Program, National Institute for Health Research UCLH/UCL Biomedical Research Centre, London, United Kingdom
⁵Division of Hematology/Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA
⁶Sanofi, Waltham, MA